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Abstract 
Background: Prevalence of cardiovascular risk factors is reported to be increasing in Ethiopia. Multimorbidity of 
these risk factors is more likely to lead cardiovascular disease (CVD) with increased hospital admission, premature 
death, and poor quality of life and increase health care expenditure. There is little evidence regarding magnitude 
and outcome of CVD multimorbidity, particularly in the African setting. The aim of this study was to examine the 
magnitude of multimorbidity and predictors of mortality in patients with cardiovascular disease admitted to the 
Medical Intensive Care Unit of St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia. 
Methods: A five-year retrospective study was conducted from 01 November 2015 to 01 January 2016. A total of 
362 patients with cardiovascular disease who were admitted to the Medical Intensive Care Unit participated in the 
study. The primary endpoint was death from any cause in the Medical Intensive Care Unit while the secondary 
was a cardiovascular composite. For baseline characteristics and survival analysis we classified patients according 
to their level of multimorbidity. We used Cox proportional hazards models to evaluate the prognostic effect of the 
level of risk factors or multimorbidity at admission while controlling for confounding variables. 
Results: A total of 71 (19.6%) patients had a diagnosis of multimorbidity. The most common cases of 
cardiovascular admission were heart failure, 137 (37.8%), acute myocardial infarction, 83 (22.9%), hemorrhagic 
stroke, 95 (26.2%) and ischemic stroke, 24 (6.6%).There were 162 (45%) deaths. Myocardial infarction (COR 0.3; 
0.18-0.53), hemorrhagic stroke (COR 3.3; 2.0-5.5) and age groups 55-64 years (COR 2.7; 1.2-6.1) and 65-74 years 
(COR 2.6; 1.1-6.1) were significantly associated with mortality.  
Conclusions: There is a significant proportion of multimorbidity in our study population. Multimorbidity may be 
used as a criterion to prioritize and improve the management of patients. Measures to prevent cardiovascular 
disease in people who already have hypertension, diabetes or underlying causes of heart failure in primary care 
settings need to be emphasized. At higher levels of care, capacity building is key to addressing the management of 
patients who present with acute cardiovascular diseases.  [Ethiop. J. Health Dev. 2018;32(4):218-224] 
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Introduction 
Multimorbidity – the simultaneous coexistence in 
individuals of more than one disease state – has 
become increasingly common in health care settings (1, 
2). Patients who have multimorbidity are more likely to 
be admitted to hospital, experience premature death or 
the loss of physical functioning, and have a poor 
quality of life (3). 
 
There is a scarcity of evidence in relation to 
appropriate interventions for patients with 
multimorbidity, as they are usually excluded from 
clinical trials (4). This limits the applicability of some 
research findings to patient groups that have 
multimorbidity (5, 6). 
 
Established cardiovascular disease (CVD), 
hypertension and diabetes are common diagnoses. 
These conditions often coexist and have increased 
prevalence with age. In patients with established CVD, 
both hypertension and diabetes are associated with a 
significantly increased risk of cardiovascular mortality 
(7-11). 
 
The significance of improving the care of patients with 
multimorbidity alongside CVD has been highlighted in 
earlier reports (10, 12).However, there is little evidence 
regarding the magnitude of multimorbidity, its 
prognosis, and predictors of mortality in patients with 
cardiovascular disease, particularly in the African 
setting.  
 
Knowledge of the magnitude of multimorbidity, 
clarifying cumulative effects on the outcomes of 
patients and identifying predictors of mortality in 
patients with CVD may help to inform the 
development of organized approaches to risk factor 
management and improve processes and outcomes for 
patients admitted to hospital settings. It also has 
implications on proper health care utilization and 
health care costs. 
 
The current study used a historical cohort of patients 
admitted to a medical intensive care unit (MICU) with 
a diagnosis of CVD. The study examined the 
magnitude of multimorbidity, whether a relationship 
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exists between the level of multimorbidity and 
cardiovascular mortality, and predictors of mortality 
among patients with CVD. 
 
Methods  
Study design and setting: From 01 November 2015 to 
01 January 2016, ahospital-based retrospective study 
was conducted on patients who were admitted to the 
Medical Intensive Care Unit (MICU) of Saint Paul’s 
Hospital Millennium Medical College (SPHMMC) 
between 11 September 2009 and 10 September 2014. 
The hospital has 364 beds and provides outpatient and 
inpatient treatment services. The MICU is a six-bed 
general intensive care unit, staffed by full-time 
intensive care doctors (pulmonary and critical care 
specialists, interns and anesthesiologists) and nurses.  
 
Study population: The study included all patients who 
were admitted to the MICU of SPHMMC with a 
diagnosis of CVD during the study period and whose 
case notes were available in the hospital registration 
archive. The study sample consisted of 362 patients 
with CVD who were admitted to the MICU and whose 
data were complete. The power of the study to detect 
statistical significance for the primary endpoint was 
82.4%.  
 
Patients were defined to have cardiovascular disorder if 
they were admitted to the MICU with a diagnosis of 
myocardial infarction, angina, heart failure, stroke, 
deep vein thrombosis, pulmonary thromboembolism, 
arrhythmia or pericarditis.  The diagnosis of the 
cardiovascular disorders was based on what physicians 
registered on the medical record. 
 
Data were collected from registry and patients’ medical 
records. Data were included on outcome variables such 
as socio-demography, confirmed admission diagnoses, 
duration of hospital stay in hours, treatment and 
outcomes, including discharge with improvement or 
transfer to ward, referral to other hospitals and death. 
These variables were examined alongside primary 
diagnoses using data from a review of patient case 
notes and then sorted using a national health 
management information system (HMIS) disease 
classification (13). Patient case notes with incomplete 
information were excluded from the study. 
Outcomes: The primary endpoint was death from any 
cause in the MICU. The secondary endpoint was a 
cardiovascular composite that included either 
myocardial infarction or stroke. 
 
Statistical analysis: For analysis of baseline 
characteristics and survival rates, patients were 
classified according to their level of multimorbidity. 
Baseline characteristics were analyzed with the use of 
mean, standard deviation, interquartile range for 
continuous variables and a chi-square for categorical 
variables. We used Cox proportional hazards models to 
evaluate the prognostic effect of the level of risk 
factors or multimorbidity at admission while 
controlling for confounding variables. Adjusted hazard 
ratios, categorized according to the level of 
multimorbidity in instances of death from any cause 
and the cardiovascular composite endpoint, were 
determined while adjusting for all other significant 
confounding variables. All statistical test values were 
two-sided, and a P-value of less than 0.05 was 
considered to indicate statistical significance. Analysis 
was carried out using SPSS (version 20.0) statistical 
software. 
 
Ethical clearance: Before starting data collection, a 
letter of support was obtained from the SPHMMC 
Ethical Review Committee. Written consent was 
obtained from the hospital administration, and 
confidentiality of information was ensured in the 




Baseline characteristics: A total of 362 patients were 
admitted to the MICU with CVD from 11 September 
2009 to 10 September 2014. About 53% were male. 
The mean age was 50 years (SD 18.4) and 281 (77.6%) 
were urban residents. The median length of stay in the 
MICU was 5.5 hours. Table 1 shows the baseline 
characteristics of the patients admitted to the MICU. 
Among the cardiovascular causes of admission, the 
most common were heart failure in 137 (37.8%), acute 
myocardial infarction in 83 (22.9%), hemorrhagic 
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Table 1: Baseline characteristics of CVD admissions, January 2016 
Variable n (%), mean (standard deviation) 
Sex 
Male 193 (53.3) 
Female 169 (46.7) 
Age (years) 
Mean  50.0 (18.4) 
Location 
Urban  281 (77.6) 
Rural 81 (22.4) 
Median length of ICU stay in hours 
(interquartile range) 
5.5 (4-12) 
Cardiovascular causes of admission 
Heart failure 137 (37.8) 
Stroke 119 (32.9) 
Hemorrhagic stroke 95 (26.2) 
Ischemic stroke 24 (6.6) 
Acute myocardial infarction 83 (22.9) 
Arrhythmia 19 (5.2) 
DVT/PTE 17 (4.7) 
Pericarditis 3 (0.8) 
Co-morbidity 
Hypertension 71 (19.6) 
Diabetes mellitus 27 (7.5) 
 
Table 2 shows the characteristics of patients with CVD 
admitted to the MICU according to the level of 
cardiovascular multimorbidity. A total of 291 (80.4%) 
patients had CVD only; 44 (12.2%) had CVD and 
hypertension; 13 (3.6%) had CVD and diabetes; and 14 
(3.9%) had CVD, hypertension and diabetes. Of the 95 
patients aged 65 years or older, 23 (24.2%) were found 
to have multimorbidity. Stroke was highest in patients 
who had hypertension, while myocardial infarction and 
heart failure were found to be highest in diabetic 
patients. 
 
Table 2: Characteristics of patients with cardiovascular disease according to level of cardiovascular 
multimorbidity, January 2016 
Characteristic CVD only  
(n = 291) 
CVD and HTN 
(n= 44) 
CVD and DM  
(n = 13) 
CVD, HTN and 
DM (n = 14) 
Mean age in years 48.8 (18.9) 52.5 (15.3) 58.1 (15.7) 61.5 (12.2) 
Female, % 137 (47.1) 25 (56.8) 5 (38.5) 2 (14.3) 
Specific CVD event   
Myocardial infarction, % 60 (20.6) 10 (22.7) 7 (53.8) 6 (42.9) 
Stroke, % 86 (29.6) 27 (61.4) – 6 (42.9) 
Heart failure*, % 119 (40.9) 9 (20.5) 6 (46.2) 3 (21.4) 
Thromboembolism: DVT, PTE, % 17 (5.8) – – – 
Arrhythmia, % 19 (6.5) – – – 
Pericarditis, % 3 (1.0) – – – 
Medication  
Aspirin, % 89 (30.6) 12 (27.3) 11 (84.6) 8 (57.1) 
Beta blocker, % 62 (21.3) 6 (13.6) 3 (23.1) 3 (21.4) 
Lipid lowering agent, % 32 (11.0) 4 (9.1) 2 (15.4) 4 (28.6) 
ACE inhibitor, % 50 (17.2) 11 (25.0) 1 (7.7) 6 (42.9) 
Total number of patients = 362; ACE = angiotensin-converting enzyme; HTN = hypertension;  
CVD = cardiovascular disease; DVT = deep vein thrombosis; PE = pulmonary embolism; 
DM = diabetes mellitus. 
* Some patients had more than one diagnosis 
 
Outcomes: A total of 162 (45%) patients died, 98 
(27%) patients improved, and 91 patients (25%) were 
transferred to other centers. Heart failure as a cause for 
ICU mortality showed a decreasing trend as the age of 
patients increased, while the other causes of ICU 
mortality increased with increasing age (Figure 1). The 
risk of death from any cause (log-rank/Mantel-Cox 
19.11, p= 0.002) was significantly increased in patients 
with stroke, myocardial infarction and heart failure 
(Figure 2). Of the cardiovascular admissions to the 
MICU and their risk factors, those that were 
significantly associated with mortality were stroke and 
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Figure 1:  Age distribution of causes of ICU death. SPHMMC, January 2016 
 
 
Table 3: Frequency and association of confirmed diagnosis with ICU mortality, January 2016 
Diagnosis n = 162 (%)  p (95% CI) 
Stroke 76 (46.9) < 0.0001 (2.04-5.10) 
Heart failure 54 (33.3) 0.11 (0.46-1.09) 
Hypertension 30 (18.5) 0.64 (0.52-1.5) 
Myocardial infarction 20 (12.3) < 0.0001 (0.18-0.53) 
Diabetes mellitus 11 (6.8) 0.66 (0.38-1.86) 
Arrhythmia 6 (3.7) 0.24 (0.2-1.5) 
 
Bivariate analysis showed that factors that were 
significantly associated with mortality were age 55-64 
years (COR 2.7; 95% CI: 1.2-6.1, p =0.02), age 65-74 
years (COR 2.6; 1.1-6.1, p= 0.03), myocardial 
infarction (COR 0.3; 0.18-0.53, p< 0.0001), and 
hemorrhagic stroke (COR 3.3; 2.0-5.5, p < 0.0001) – 
see Table 4.  
 
 
Table 4: Bivariate analysis of age group, MI, ischemic stroke and hemorrhagic stroke with ICU mortality, 
January 2016 
Age (years) n (%) COR (95% CI), p 
< 25  12 (7.4) 1.00 
25-34 21 (13.0) 2.1 (0.9-5.2),0.1 
35-44 18 (11.1) 1.3 (0.5-3.1), 0.6 
45-54 28 (17.3) 2.0 (0.9-4.6),0.11 
55-64 38 (23.5) 2.7 (1.2-6.1), 0.02 
65-74 30 (18.5) 2.6 (1.1-6.1), 0.03 
> 74 15 (9.3) 1.5 (0.6-3.9),0.38 
Death from myocardial infarction 
No 63 (75.9) 1.00 
Yes 20 (24.1) 0.3 (0.18-0.53), < 0.0001 
Death from hemorrhagic stroke 
No 32 (33.7) 1.00 
Yes 63 (66.3)  3.3 (2.0-5.5), < 0.0001 
Death from ischemic stroke 
No 11 (45.8) 1.00 
Yes 13 (54.2) 1.5 (0.7-3.4), 0.34 
Death from myocardial infarction or stroke 
Female 44 (45.8) 1.00 
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In the examination of the relationship between the 
secondary outcomes and the level of risk factors or 
multimorbidity while controlling for confounding 
variables, patients with no hypertension and no 
diabetes were used as the reference group (see Table 
2). The confounding variables available for inclusion in 
the Cox proportional hazards model were age groups 
and sex. The adjusted hazard ratios (AHRs) for the 
secondary outcomes according to the level of risk 
factors or multimorbidity are given in Table 5. The 
estimated risk of the cardiovascular composite 
(secondary) endpoint, when compared with patients 
with no diabetes mellitus and no hypertension, was 
1.61 (95% CI: 1.12-2.32) for patients with 
hypertension. This compares with 1.96 (95%CI: 0.91-
4.21) for patients with diabetes; and 1.31(95%CI: 0.72-
2.39) for patients with both diabetes and hypertension.  
 
Table 5: Adjusted hazard ratios for secondary endpoints among patients according to presence  
of risk factors or multimorbidity, January 2016* 
Level of cardiovascular risk factor Secondary endpoint: cardiovascular 
composite 
 p-value AHR (95% CI) 
No hypertension and no diabetes mellitus – 1.00 
Hypertension 0.01 1.61 (1.12-2.32) 
Diabetes mellitus 0.09 1.96 (0.91-4.21) 
Hypertension and diabetes mellitus 0.38 1.31 (0.72-2.39) 
Total number of patients = 362  
*Cox proportional hazards model used in the above analysis adjusted for the covariates age and sex 
 
When modelling the cardiovascular composite 
endpoint, there was evidence of a significant 
interaction between diabetes and myocardial infarction 
(AHR 4.33; 95% CI: 1.96-9.58, p< 0.0001) and 
between hypertension and hemorrhagic stroke (AHR 
2.27; 95% CI: 1.42-3.63, p = 0.001). There was also 
evidence of a significant interaction between heart 
failure and diabetes (AHR 3.31; 95% CI: 1.43-7.68, p = 
0.005) and between heart failure and hypertension 




Figure 2.Kaplan–Meier survival plots for risk of ‘death from any cause’ according to CVD admission 
diagnosis, January 2016 
 
Discussion 
This study of patients admitted to the MICU of 
SPHMMC with CVD revealed the presence of a 
significant proportion of cardiovascular 
multimorbidity. About 20% of the patients admitted 
with CVD had diabetes mellitus, hypertension or both. 
The prevalence of cardiovascular multimorbidity in 
this study population is probably an actual estimate for 
the specific study group, particularly in light of the 
proportion of patients with hypertension and diabetes 
compared with other populations in Ethiopia (14-17). 
But it is lower than other population surveys that 
suggest up to 30% of adults suffer from more than one 
non-communicable disease (18-20). 
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In our study, the presence of multimorbidity appears to 
be a significant risk factor for mortality and 
cardiovascular morbidity. The overall mortality in the 
MICU was significantly higher in the age groups 55-74 
years, and in those with hemorrhagic stroke. While 
heart failure was the most common cause of ICU 
mortality in younger patients, stroke and myocardial 
infarction were predominant in older age groups.  
 
Unlike other studies that found a strong association 
between baseline CVD (i.e., a history of stroke or MI) 
and reduced survival for men compared to women, in 
our study there is no significant difference in mortality 
from MI or stroke between males and females (21). 
 
The greatest proportion of deaths in our study was from 
cerebrovascular accidents or stroke, rather than from 
heart failure or ischemic heart disease. This concurs 
with Morrish et al.’s follow-up study (22) of the WHO 
Multinational Study of Vascular Disease in Diabetes, 
which found that, across 10 centers throughout the 
world, cerebrovascular deaths were more common than 
deaths from ischemic heart disease among people with 
Type 2 diabetes in Tokyo and Hong Kong, those with 
Type 1 diabetes in Zagreb, and men with Type 1 
diabetes in Hong Kong. This study also reported that 
ischemic heart disease accounted for the greatest 
proportion of CV deaths in all other centers (23). 
 
Patients with diabetes have an increased risk of 
myocardial infarction and heart failure contributing 
more to ICU morbidity, while those with hypertension 
have an increased risk of heart failure and hemorrhagic 
stroke that was found to be the strongest risk factor for 
ICU mortality in these patients. Other studies reveal 
that, following myocardial infarction, diabetes appears 




In this study we found a significant proportion of 
multimorbidity in patients admitted to MICU with a 
CVD diagnosis. The risk of death from any cause was 
higher in patients with stroke, myocardial infarction, 
heart failure, and among those in the 55-74 years age 
group. The strongest predictors of mortality in the 
MICU were 55-74 years age group, and admission with 
hemorrhagic stroke. 
 
Multimorbidity may be used as a tool to prioritize the 
management of patients with or without CVD. This is 
of particular interest in light of the planned focus on 
the prevention and management of non-communicable 
diseases by the World Health Organization (22). 
 
Our results emphasize the importance of measures to 
prevent CVD in people who already have hypertension, 
diabetes, or underlying causes of heart failure in 
primary care settings. On the other hand, at higher 
levels of care, strategies for preventing hypertension 
and diabetes in people who already have CVD and 
capacity building, to enable early management of 
patients presenting with acute CVD, is indispensable to 
improve patients’ survival, physical functioning, and 
quality of life. Moreover, prevention of the risk factors 
to reduced CVD multimorbidity has a considerable 
impact on health care utilization and health care costs. 
 
Limitations of the study 
This study had a number of limitations. First, because 
the data were collected retrospectively, information 
bias is a limitation, as the records were not complete 
and we had no control over the quality of previously 
recorded data. In addition, the cohort was a 
cardiovascular population in which multimorbidity was 
then identified, and not a de novo population with 
multimorbidity. Although the presence of hypertension 
and diabetes appear to discriminate prognosis between 
patients with established CVD, it is difficult to identify 
the different elements of this association, as the 
confounding factors addressed in this study are limited 
and sample size is underpowered to detect significant 
differences for the secondary endpoint. Another 
limitation is that the study sample was from a single-
center MICU, although it is reasonable to assume that 
the results are fairly generalizable to other similar 
facilities in Ethiopia. As this is the first in Ethiopia to 
report on the comparative risks associated with 
multimorbid conditions in patients admitted to MICU 
with CVD, it needs to be verified by prospective 
multisite studies.  
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